<DOC>
	<DOCNO>NCT02192333</DOCNO>
	<brief_summary>This randomize clinical trial study survivorship care reduce symptom young adult cancer survivor . Survivorship care program identify need young adult cancer survivor way support year treatment may help reduce symptom , pain , fatigue , sleep disturbance , depression , distress , young adult cancer survivor .</brief_summary>
	<brief_title>Survivorship Care Reducing Symptoms Young Adult Cancer Survivors</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To test impact provide essential element survivorship care survivorship outcomes indicated reduction symptom ( pain , fatigue , sleep disturbance , depression , distress ) young adult cancer survivor diagnose cancer age 18 39 year compare usual care . SECONDARY OBJECTIVES : I . To improve confidence survivorship knowledge promote healthy lifestyle behavior . II . To provide evidence barrier , need care preference support long term follow-up recommendation population . OUTLINE : Participants categorize high-need randomized 1 2 arm . Participants categorize low-need assigned Arm I . ARM I : Participants receive usual care . After 12 month , participant may receive survivorship clinic visit booster Arm II . ARM II : Participants attend survivorship clinic visit include care plan , screen recommendation , physician coordination , health promotion education , symptom management palliative care , late effect education , psychosocial medical assessment , referral service care appropriate . Participants also receive phone-based survivorship booster approximately 15-30 minute 4-6 week 12-14 week initial clinic visit . After completion study , participant follow 6 12 month .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Genital Neoplasms , Female</mesh_term>
	<mesh_term>Genital Neoplasms , Male</mesh_term>
	<criteria>Patients enrol phase 1 study eligible ( and/or recruit tumor registry clinic followup schedule ) Diagnosed invasive malignancy include : breast , gastrointestinal track , female male genitourinary system , sarcoma bone softtissue , leukemia lymphoma Treated one Survivorship Centers Excellence community affiliate Received therapeutic intervention least one follow modality : surgery , cytotoxic chemotherapy , biological target agent , radiation therapy ( modality ) Currently 1.0 4.99 year completion active cancerdirected therapy ( cytotoxic chemotherapy , radiation therapy and/or definitive surgical intervention ) Patient must still active followup : see followup visit participate center least 3 year prior enrollment and/or schedule see followup next 6 month ( i.e . active followup ) May receive `` maintenance '' therapy goal prevention recurrence expectation active treatment Able read speak English adequate complete patientreported outcome ( PRO ) assessment Prior visit survivorship clinic previously provide treatment summary care plan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>